UK markets closed

EVRAZ plc (EVR.L)

LSE - LSE Delayed price. Currency in GBp (0.01 GBP)
Add to watchlist
81.00+0.11 (+0.14%)
At close: 10:05AM GMT
Full screen
Previous close80.89
Open81.00
Bid0.00 x 0
Ask0.00 x 0
Day's range81.00 - 81.00
52-week range0.81 - 81.00
Volume13,219
Avg. volume0
Market cap1.182B
Beta (5Y monthly)0.92
PE ratio (TTM)0.42
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yield0.76 (93.41%)
Ex-dividend date10 Mar 2022
1y target estN/A
  • EQS Group

    DISCONTINUATION OF DISCLOSURE VIA PRIMARY INFORMATION PROVIDER

    EVRAZ plc (EVR) DISCONTINUATION OF DISCLOSURE VIA PRIMARY INFORMATION PROVIDER 28-Feb-2023 / 10:00 MSK The issuer is solely responsible for the content of this announcement. DISCONTINUATION OF DISCLOSURE VIA PRIMARY INFORMATION PROVIDER 28 February 2023 - EVRAZ plc (“EVRAZ” or the “Company”) announces that starting from 1 March 2023 the Company will not be able to release regulatory news announcements via a primary information provider (“PIP”). In May 2022, EVRAZ was informed by the RNS, its PIP

  • EQS Group

    CLARIFICATION ON ANNUAL REPORT AND AUDITED FINANCIAL STATEMENTS FOR 2022

    EVRAZ plc (EVR) CLARIFICATION ON ANNUAL REPORT AND AUDITED FINANCIAL STATEMENTS FOR 2022 27-Feb-2023 / 10:00 MSK The issuer is solely responsible for the content of this announcement. CLARIFICATION ON ANNUAL REPORT AND AUDITED FINANCIAL STATEMENTS FOR 2022 27 February 2023 - EVRAZ plc (“EVRAZ” or the “Company”) announces that the Company has not been able to engage an auditor in respect of its most recent financial year ended 31 December 2022 in light of UK sanctions imposed against EVRAZ. The C

  • EQS Group

    EVRAZ plc announces that the Appointment and the Amendments adopted as part of the Consent Solicitation for its outstanding U.S.$700,000,000 5.250 per cent. notes due 2024 have become effective

    EVRAZ plc (EVR) EVRAZ plc announces that the Appointment and the Amendments adopted as part of the Consent Solicitation for its outstanding U.S.$700,000,000 5.250 per cent. notes due 2024 have become effective 28-Dec-2022 / 10:30 MSK Dissemination of a Regulatory Announcement, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement. NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO, OR TO ANY PERSON LOCATED OR RESIDENT IN, ANY JURISDICTION WHERE IT I